Back to top

TRAW Moves TRX-100 Through Early Human Testing: What Investors Should Watch

Traws Pharma, Inc. ($TRAW) announced an update on their ongoing clinical study. Traws Pharma, Inc. (TRAW) is running a Phase 1 study called “A Rand...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Traws Pharma, Inc. (TRAW)